0000908662-16-000404.txt : 20160119 0000908662-16-000404.hdr.sgml : 20160118 20160119162319 ACCESSION NUMBER: 0000908662-16-000404 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160114 FILED AS OF DATE: 20160119 DATE AS OF CHANGE: 20160119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 BUSINESS PHONE: 617-250-5769 MAIL ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MIGAUSKY GEORGE V CENTRAL INDEX KEY: 0001134365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24537 FILM NUMBER: 161348570 MAIL ADDRESS: STREET 1: C/O DYAX CORP. STREET 2: 300 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-01-14 0000907562 DYAX CORP DYAX 0001134365 MIGAUSKY GEORGE V C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803-2756 0 1 0 0 EVP & Chief Financial Officer Common Stock 2016-01-14 4 M 0 42734 2.39 A 405698 D Common Stock 2016-01-14 4 M 0 87729 3.22 A 493427 D Common Stock 2016-01-14 4 M 0 50007 3.00 A 543434 D Common Stock 2016-01-14 4 M 0 91042 1.48 A 634476 D Common Stock 2016-01-14 4 M 0 39999 2.06 A 674475 D Common Stock 2016-01-14 4 M 0 15000 10.20 A 689475 D Common Stock 2016-01-14 4 M 0 62500 15.23 A 751975 D Common Stock 15000 I By Trust Stock Option (right to buy) 2.39 2016-01-14 4 M 0 42734 0 D 2019-02-11 Common Stock 42734 0 D Stock Option (right to buy) 3.22 2016-01-14 4 M 0 87729 0 D 2020-02-10 Common Stock 87729 0 D Stock Option (right to buy) 3.00 2016-01-14 4 M 0 50007 0 D 2023-02-07 Common Stock 50007 37916 D Stock Option (right to buy) 1.48 2016-01-14 4 M 0 91042 0 D 2022-02-24 Common Stock 91042 3958 D Stock Option (right to buy) 2.06 2016-01-14 4 M 0 39999 0 D 2018-08-06 Common Stock 39999 0 D Stock Option (right to buy) 10.20 2016-01-14 4 M 0 15000 0 D 2024-02-27 Common Stock 15000 63912 D Stock Option (right to buy) 15.23 2016-01-14 4 M 0 62500 0 D 2025-02-18 Common Stock 62500 228388 D Shares are held in trusts, of which Mr. Migausky is the trustee, for the benefit of each of Mr. Migausky's children. Mr. Migausky disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. The options became fully exercisable on February 11, 2013. The options became fully exercisable on February 10, 2014. The options become exercisable in 48 substantially equal installments at the end of each monthly anniversary of the date of grant, February 7, 2013. The options become exercisable in 48 substantially equal installments at the end of each monthly anniversary of the date of grant, February 24, 2012. The options became fully exercisable on June 20, 2014. The options become exercisable in 48 substantially equal installments at the end of each monthly anniversary of the date of grant, February 27, 2014. The options become exercisable in 48 substantially equal installments at the end of each monthly anniversary of the date of grant, February 18, 2015. /s/ Stacie S. Aarestad as attorney-in-fact 2016-01-19